Legal Representation
Attorney
B. Brett Heavner
USPTO Deadlines
Application History
14 events| Date | Code | Type | Description |
|---|---|---|---|
| Jan 20, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Jan 20, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Jan 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 5, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jan 5, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jan 5, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 19, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 24, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 24, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 4, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 18, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 12, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 6, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 10, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
human pharmaceuticals for the prevention, diagnosis, and treatment of cardiovascular diseases and conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...